Close Menu

NEW YORK (GenomeWeb) – Fluidigm reported after the close of the market on Thursday that its fourth quarter revenues jumped 17 percent year over year driven in large part by its mass cytometry business.

For the three months ended Dec. 31, the South San Francisco, California-based life science research tools firm tallied revenues of $32.3 million compared to $27.7 million a year ago and besting analysts' average estimate of $30.6 million. The company also bested previous guidance of Q4 revenues of $29 million to $32 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.